SEC Form 4 · accession 0001209191-16-156270
Orexigen Therapeutics, Inc. · OREXQ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen A. Moglia
Officer — VP, Chief Accounting Officer
Period of report
Dec 19, 2016
Accepted (ET)
Dec 21, 2016 · 12:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001382911
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 19, 2016 | S | 800 | $1.96 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.